Funding for cancer research and investigator training
Official title: Developmental Funds
Funded at University of Rochester · NIH-11014532 · Data updated 2026-11-12
This study is all about helping new cancer researchers get started by giving them funding and support, so they can come up with fresh ideas that could lead to better treatments for patients like you.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project start | March 15, 2025 |
| Project end | February 28, 2030 |
| Funding year | 2025 |
| Award (this year) | $431,200 |
| NIH project number | 1P30CA272302-01A1 |
| Project ID | NIH-11014532 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research are individuals affected by cancer, particularly those involved in community-based research initiatives.
✕Less likely to help
Patients with conditions unrelated to cancer or those not engaged in community research efforts may not receive direct benefits from this research.
What this research studies
This research focuses on providing developmental funds to support innovative cancer research projects and the training of early-stage clinical investigators. The Wilmot Cancer Institute aims to foster collaboration among researchers and enhance career development opportunities for those entering the field of cancer research. By offering seed grants and mentorship, the program seeks to build a strong foundation for future research initiatives that address critical areas such as aging and cancer. Patients may benefit from the advancements in cancer treatment and care that arise from these collaborative efforts.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer treatments and better outcomes for patients.
How similar studies have gone: Other research initiatives that focus on collaborative cancer research and investigator training have shown success in advancing treatment options and improving patient outcomes.
Where this research is happening
-
University of Rochester
Rochester, United States Active
Researchers
- Principal investigator: Friedberg, Jonathan W — University of Rochester
- Study coordinator: Friedberg, Jonathan W
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.